Discover 1,665 paid clinical trials in Colorado. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Colorado offers a variety of paid research opportunities, including paid studies for healthy volunteers and trials for those with specific health needs. Research hubs in Denver, Colorado Springs, and Boulder are actively recruiting participants, providing access to innovative treatments and exceptional medical care.
Filter
1
Filter results
Results: 1,665
A Study of D3S-001 Monotherapy or Combination Therapy in Subjects With Advanced Solid Tumors With a KRAS p.G12C Mutation
for
KRAS P.G12C
Location: Sarasota FL, Detroit MI, Nashville TN, Houston TX,
Sponsor: D3 Bio (Wuxi) Co., Ltd
Sex: All
Age: 18+
Code: NCT05410145
Phase1, Phase2, Recruiting
A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine
for
Acute Migraine
Location: Boston MA, Waltham MA, Waterbury CT, Commack NY,
Sponsor: Kallyope Inc.
Sex: All
Age: 18+
Code: NCT07674654
Phase3, Recruiting
Study of Choline Chloride for Injection in Adolescent and Adult Patients With Intestinal Failure Receiving Long Term Parenteral Support
for
Choline Deficiency, Liver Injury
Location: Durham NC, Miami Lakes FL, Cleveland OH, Chicago IL,
Sponsor: Protara Therapeutics
Sex: All
Age: 12+
Code: NCT06910943
Phase2, Phase3, Recruiting
Safety and Effectiveness of the PXL Platinum 330 System With Riboflavin Solution for Previously Untreated Corneal Ulcers
for
Keratitis, Corneal Ulcer
Location: Babylon NY, Teaneck NJ, Columbia SC, Fort Myers FL,
Sponsor: Peschke GmbH
Sex: All
Age: 18+
Code: NCT05255107
Phase2, Phase3, Recruiting
REVEAL: A Phase 3 Study of Obudanersen (ION582) in Angelman Syndrome
for
Angelman Syndrome
Location: Boston MA, New York NY, Montreal, Philadelphia PA,
Sponsor: Ionis Pharmaceuticals, Inc.
Sex: All
Age: 2 - 50
Code: NCT06914609
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
MEKTOVI® for the Treatment of Pediatric Adamantinomatous Craniopharyngioma
for
Adamantinous Craniopharyngioma,
Location: Montreal, Washington D.C. DC, Miami FL, Columbus OH,
Sponsor: Nationwide Children's Hospital
Sex: All
Age: 1 - 39
Code: NCT05286788
Phase2, Recruiting
Phase 2b Study of RPT904 as Monotherapy in Participants With IgE-Mediated Food Allergy
for
Ig-E Mediated Food Allergy
Location: Boston MA, Great Neck NY, New York NY, Montreal,
Sponsor: RAPT Therapeutics, Inc.
Sex: All
Age: 12 - 55
Code: NCT07220811
Phase2, Recruiting
Macrophage Programing in Acute Lung Injury: MiniBAL
for
Acute Respiratory Distress Syndrome,
Location: Denver CO
Sponsor: William Janssen, MD
Sex: All
Age: 18 - 70+
Code: NCT05767671
Recruiting
Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Advanced Sarcoma
for
Metastatic Dedifferentiated Liposarcoma,
Location: Boston MA, Baltimore MD, Bethesda MD,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT05711615
Phase1, Recruiting
Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer
Location: Hartford CT, New York NY, Philadelphia PA, Norfolk VA,
Sponsor: Endospan Ltd.
Sex: All
Age: 18+
Code: NCT04471909
Recruiting
Placebo-Controlled Trial of IFx-Hu2.0 Followed By Pembrolizumab In Checkpoint Inhibitor Naïve Participants With Advanced Or Metastatic Merkel Cell Carcinoma
for
Advanced Or Metastatic Merkel Cell Carcinoma
Location: Boston MA, Hackensack NJ, Morristown NJ, Greenville NC,
Sponsor: TuHURA Biosciences, Inc.
Sex: All
Age: 18+
Code: NCT06947928
Phase2, Phase3, Recruiting
A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma
for
Low Grade Astrocytoma, Low Grade Glioma,
Location: St. John's, Halifax, Bangor ME, Scarborough ME,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 2 - 21
Code: NCT04166409
Phase3, Recruiting
Genetic Regulators of Bone Health That Are Unique to Vertebral Bone
for
Age-Related Osteoporosis
Location: Aurora CO
Sponsor: University of Colorado, Denver
Sex: All
Age: 18 - 70+
Code: NCT05946278
Recruiting
First In Human Study of CX-2051 in Advanced Solid Tumors
for
Solid Tumor, Adult
Location: Boston MA, The Bronx NY, Fairfax VA, Huntersville NC,
Sponsor: CytomX Therapeutics
Sex: All
Age: 18+
Code: NCT06265688
Phase1, Recruiting
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
for
AML, AML With Mutated NPM1, Hematologic Malignancy, KMT2Ar,
Location: Boston MA, New Haven CT, Stony Brook NY,
Sponsor: Kura Oncology, Inc.
Sex: All
Age: 18+
Code: NCT06001788
Phase1, Recruiting
Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥ 50% (MK-2870-007)